Skip to main content
Erschienen in: Intensive Care Medicine 12/2016

29.09.2016 | Focus Editorial

Focus on adequate antimicrobial treatment and de-escalation in the ICU

verfasst von: Dominique D. Benoit, Gordon Doig, Jean-Francois Timsit

Erschienen in: Intensive Care Medicine | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Excerpt

Adequate antimicrobial treatment is considered of upmost importance to reduce mortality in critically ill patients with infection. However, because of the dramatic increase of antibiotic resistance worldwide [1, 2] and the delay in microbiological identification of pathogens, adequate antibiotic treatment is more easy to define retrospectively on chart review than to implement prospectively at the bedside. Several articles recently published in Intensive Care Medicine have provided some clues in how to improve adequate antimicrobial treatment in daily practice. …
Literatur
1.
Zurück zum Zitat Carlet J (2014) Ten tips on how to win the war against resistance to antibiotics. Intensive Care Med 41:899–901CrossRef Carlet J (2014) Ten tips on how to win the war against resistance to antibiotics. Intensive Care Med 41:899–901CrossRef
2.
Zurück zum Zitat Bassetti M, Nicolau DP, Calandra T (2014) What’s new in antimicrobial use and resistance in critically ill patients. Intensive Care Med 40:422–426CrossRefPubMed Bassetti M, Nicolau DP, Calandra T (2014) What’s new in antimicrobial use and resistance in critically ill patients. Intensive Care Med 40:422–426CrossRefPubMed
3.
Zurück zum Zitat Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795CrossRefPubMed Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795CrossRefPubMed
4.
Zurück zum Zitat Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92–95CrossRefPubMed Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92–95CrossRefPubMed
5.
Zurück zum Zitat Paul M, Lador A, Grozinsky-Glasberg Leibovici L (2014) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 7(1):CD003344 Paul M, Lador A, Grozinsky-Glasberg Leibovici L (2014) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 7(1):CD003344
6.
Zurück zum Zitat Paul M, Dickstein Y, Schlesinger A, Grozinsky-Glasberg S, Soares-Weiser L, Leibovici L (2013) Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev 29(6):CD003038 Paul M, Dickstein Y, Schlesinger A, Grozinsky-Glasberg S, Soares-Weiser L, Leibovici L (2013) Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev 29(6):CD003038
7.
Zurück zum Zitat Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Phiippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP (2015) Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med 41:1181–1196CrossRefPubMed Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Phiippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP (2015) Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med 41:1181–1196CrossRefPubMed
8.
Zurück zum Zitat de Lastours V, Chau F, Roy C, Larroque B, Fantin B (2014) Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother 69:3393–3400CrossRefPubMed de Lastours V, Chau F, Roy C, Larroque B, Fantin B (2014) Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother 69:3393–3400CrossRefPubMed
9.
Zurück zum Zitat Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ (2014) Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med 40:564–571CrossRefPubMedPubMedCentral Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ (2014) Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med 40:564–571CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat De Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med 40:998–1005CrossRefPubMed De Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med 40:998–1005CrossRefPubMed
11.
Zurück zum Zitat Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083CrossRefPubMed Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083CrossRefPubMed
12.
Zurück zum Zitat De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically patients. Intensive Care Med 40:1340–1351CrossRefPubMed De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA (2014) Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically patients. Intensive Care Med 40:1340–1351CrossRefPubMed
13.
Zurück zum Zitat Matthaiou DK, De Waele J, Dimopoulos G (2014) What is new in the use of aminoglycosides in critically ill patients? Intensive Care Med 40:1553–1555CrossRefPubMed Matthaiou DK, De Waele J, Dimopoulos G (2014) What is new in the use of aminoglycosides in critically ill patients? Intensive Care Med 40:1553–1555CrossRefPubMed
14.
Zurück zum Zitat De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimization of piperacillin and meropenem: a randomized controlled trial. Intensive Care Med 40:380–387CrossRefPubMed De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimization of piperacillin and meropenem: a randomized controlled trial. Intensive Care Med 40:380–387CrossRefPubMed
15.
Zurück zum Zitat De Pascale G, Fortuna S, Tumbarello M, Cutuli SL, Vallecoccia MS, Spanu T, Bello G, Montini L, Pennisi MA, Navarra P, Antonelli M (2015) Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration. Intensive Care Med 41:103–110CrossRefPubMed De Pascale G, Fortuna S, Tumbarello M, Cutuli SL, Vallecoccia MS, Spanu T, Bello G, Montini L, Pennisi MA, Navarra P, Antonelli M (2015) Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration. Intensive Care Med 41:103–110CrossRefPubMed
16.
Zurück zum Zitat Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Marquez-Vacaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40CrossRefPubMed Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Marquez-Vacaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32–40CrossRefPubMed
17.
Zurück zum Zitat Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bézulier K, Antonini F, Textoris J, Martin C, for the AZUREA Network Investigators (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399–1408CrossRefPubMed Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bézulier K, Antonini F, Textoris J, Martin C, for the AZUREA Network Investigators (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399–1408CrossRefPubMed
18.
Zurück zum Zitat Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49CrossRefPubMed Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49CrossRefPubMed
19.
Zurück zum Zitat Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Inf: S1198-743X(16)30175-6. doi:10.1016/j.cmi.2016.05.023 Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Inf: S1198-743X(16)30175-6. doi:10.​1016/​j.​cmi.​2016.​05.​023
20.
Zurück zum Zitat Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071–1080CrossRefPubMedPubMedCentral Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071–1080CrossRefPubMedPubMedCentral
Metadaten
Titel
Focus on adequate antimicrobial treatment and de-escalation in the ICU
verfasst von
Dominique D. Benoit
Gordon Doig
Jean-Francois Timsit
Publikationsdatum
29.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 12/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4566-2

Weitere Artikel der Ausgabe 12/2016

Intensive Care Medicine 12/2016 Zur Ausgabe

Imaging in Intensive Care Medicine

Ultrasonographic diagnosis of tracheal compression

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.